eMedicine World Medical Library

Excerpt from Intrauterine Growth Retardation


Synonyms, Key Words, and Related Terms: IUGR, intrauterine growth restriction, fetal growth, small for gestational age, asymmetric IUGR, symmetric IUGR, asymmetrical IUGR, symmetrical IUGR, growth-restricted fetus, transcerebellar diameter, head-sparing effect, abdominal circumference, head circumference, biparietal diameter, oligohydramnios

Please click here to view the full topic text: Intrauterine Growth Retardation

Background

The term intrauterine growth restriction has largely replaced the term intrauterine growth retardation (IUGR). The definition of IUGR is a problematic one because we do not know the inherent growth potential of the fetus. The most common definition used is fetal weight below the 10th percentile for gestational age.

In most cases of fetal growth restriction, the transcerebellar diameter appears to be spared and can be used as an unbiased measure of gestational age. The transcerebellar diameter in millimeters is equal to gestational age in weeks to 22 weeks of gestation. With this definition, IUGR and "small for gestational age" are synonymous terms.

IUGR has a prevalence of 10% for all pregnancies. However, the figure varies in different patient populations, with rates of 3-5% for healthy mothers and 25% or higher for some high-risk groups, such as hypertensive mothers. Growth-restricted pregnancies are often complicated by a high rate of antepartum and intrapartum fetal distress and the need for cesarean delivery. Infants who are small for their gestational dates are predisposed to low APGAR scores, low cord pH, intraventricular hemorrhage, necrotizing enterocolitis, hypoglycemia, hypocalcemia, and polycythemia.

For excellent patient education resources, visit eMedicine's Pregnancy and Reproduction Center.

Pathophysiology

Etiology

The causes of IUGR can be either fetal or maternal.

Fetal causes of IUGR include aneuploidy, trisomy 13, trisomy 18, triploidy, intrauterine infection, cytomegaloviral infection, and toxoplasmosis.

Maternal causes of IUGR include use of drugs (including recreational drugs such as marijuana), alcohol consumption, placental insufficiency, diabetes, late conception (possible cause), and a history of having a baby small for his or her age.

Asymmetrical vs symmetrical IUGR

In most cases of IUGR, especially those due to primary placental insufficiency, the fetal abdomen is small, but the head and extremities are normal or near normal. This finding is known as the head-sparing effect. In cases of severe, early-onset IUGR (those due to chromosomal anomalies), the fetus tends to be more symmetrically small. This condition leads to the existence of 2 distinct subgroups; however, these subgroups significantly overlap.

Fetal villus circulation

The placenta is the lifeline to the fetus, and when challenged, it has a remarkable ability to adapt. Developmental problems can occur from the maternal side, the fetal side, or both. To understand these problems, knowledge of the development and the physiology of the villus circulation is needed.

In the first trimester, the endometrium is invaded by the mesenchymal villi, which are made up of trophoblast, stroma, and a core of vessels. Early in pregnancy, the mesenchymal villi transform into immature intermediate stem villi, which then differentiate into stem villi. The primary-, secondary-, and tertiary-stem villi form the scaffolding from which subsequent villi develop. The histologic structure of the terminal villi optimizes maternal-fetal transfer of nutrients and oxygen. Vascularization of the villi occurs in the first and second trimesters by the process of branching angiogenesis.

Three basic theories regarding the mechanics of the placental circulation are described. As reported in one color Doppler investigation, the theory that best suits these findings is the Ramsey theory. In this mechanism, blood enters the intervillous spaces via the spiral arteries. While moving within the intervillous space, the maternal blood bathes the individual units, which are composed of a fetal arterial, venous, and capillary network. The maternal blood then leaves the intervillous space by the draining basal veins.

The transfer of oxygen and nutrients occurs at the interface between the terminal and intermediate mature villi and the intervillous space. Oxygen and nutrients enter the fetal villous venous circulation and are transferred to the fetus via the umbilical cord.

Kingdom et al demonstrated that maldevelopment of the villus tree in pregnancies complicated by fetal growth restriction is associated with abnormal uterine artery waveforms, which are Doppler findings indicating abnormal uteroplacental blood flow. In pregnancies also complicated by absent end-diastolic umbilical flow, the placental villi are elongated, and the capillary loops are uncoiled and sparse. These findings are correlated with an increase in fetal-placental vascular impedance and impair gas and nutrient exchange. An enhanced branching angiogenesis represents an adaptive response to impaired uteroplacental blood flow.

Frequency

United States

By definition, the prevalence of IUGR is 10%; fetuses with an estimated weight of less than 10% for gestational age are defined as being growth restricted.

Mortality/Morbidity

The perinatal mortality for infants with IUGR is 6-10 times greater than that of a normal-growth population. IUGR is a major cause of intrapartum fetal distress, intrapartum asphyxia, hypoglycemia, hypocalcemia, meconium aspiration, and intrauterine demise.

Sex

This condition affects only pregnant women.

Age

The incidence of IUGR increases with increasing maternal age.

Clinical Details

IUGR is usually related to preeclampsia.

Preferred Examination

The preferred method for evaluating the IUGR is ultrasonographic examination.

Please click here to view the full topic text: Intrauterine Growth Retardation

About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers
Labelled with ICRA © 1996-2006 by WebMD.
All Rights Reserved.

Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER